other cryptocurrency Featured snippets

Putin signed a decree to extend the measures to counter the western oil price limit against Russia again. On December 13th, local time, according to the documents published on the Russian legal information portal, Russian President Vladimir Putin has signed an order to extend the special economic measures formulated because western countries impose price limits on Russian oil and petroleum products until June 30th, 2025. Since the law came into effect on February 1, 2023, the validity of the measures has been extended several times. The decree stipulates that if the contract directly or indirectly stipulates the price ceiling set by other countries, it is forbidden to export Russian petroleum and petroleum products according to the contract, and the signed ban applies to all supply stages before delivery to buyers. (CCTV News)GCL Technology: It is estimated that there will be no more share repurchase cancellation in 2024. GCL Technology (03800) announced that in view of the fact that the photovoltaic industry is still in excessive competition, in order to ensure the stability of the company's operation and cope with the uncertainty in the future, the company expects that there will be no more share repurchase cancellation in the year ending December 31, 2024.Zhuhai Guanyu: It has been notified by domestic car companies. Zhuhai Guanyu announced that the company has recently been notified by a domestic car company to select the company as its designated supplier to develop and supply low-voltage lithium batteries for 12V cars.

General Administration of Financial Supervision: Help boost consumer support and expand bulk consumption, service consumption and new consumption. The Party Committee of the State Financial Supervision and Administration held a meeting to convey the spirit of studying the Central Economic Work Conference. The meeting requested that the real economy should be better served to help boost consumption and support the expansion of bulk consumption, service consumption and new consumption. Strengthen the financing guarantee for investment and effectively serve the "double" and "two new". Expand the pilot of equity investment of financial asset investment companies in an orderly manner. Do a solid job in supporting the financing coordination mechanism of small and micro enterprises. Increase financial support for foreign trade enterprises and strengthen export credit insurance and credit services. Actively guide banks and insurance institutions to reduce costs and increase efficiency, broaden capital replenishment channels, and improve their sustainable development capabilities. Promote high-level financial openness with higher standards and greater efforts, and attract more foreign financial institutions and long-term capital to set up businesses in China.Canada recorded a monthly wholesale sales rate of 1% in October, the largest increase since April 2024. Canada recorded a monthly wholesale sales rate of 1% in October, with an expected 0.5% and a previous value of 0.80%. Canada's annual wholesale sales rate in October was 1.7%, and the previous value was -0.4%. Canada's annual wholesale inventory rate in October was -1%, and the previous value was 0.7%. The monthly rate of wholesale inventory in Canada in October was 0.9%, and the previous value was 0.2%. The monthly inventory rate of manufacturing industry in Canada in October was 0.2%, and the previous value was -0.4%. The monthly rate of new manufacturing orders in Canada in October was -0.9%, and the previous value was 3.9%. The monthly rate of unfinished orders in Canada's manufacturing industry in October was -0.2%, and the previous value was 1.6%. Canada's capacity utilization rate in the third quarter was 79.3%, with an expected 78.9% and a previous value of 79.10%. Canada's manufacturing inventory shipment ratio in October was 1.69%, and the previous value was 1.74%.Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.

Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.The balance of A-share financing reached a new high in nine years. Since the fourth quarter, the net purchase amount of financing in 12 industries has exceeded 10 billion yuan. As of December 12, the balance of A-share financing was 1,882.656 billion yuan, a new high since August 2015. Since the fourth quarter, the market financing balance has grown rapidly. The latest financing balance was 1,882.656 billion yuan, an increase of 452.006 billion yuan or 31.59% compared with the financing balance of 1,430.650 billion yuan on September 30. During the period, the net purchase amount of financing in 12 industries exceeded 10 billion yuan. Electronics, computers, non-bank finance and machinery and equipment ranked in the top four, with the amounts of 77.849 billion yuan, 50.709 billion yuan, 49.201 billion yuan and 31.068 billion yuan in turn. In proportion, the latest financing balance of electronics, mechanical equipment and computers increased by more than 50% compared with that before the fourth quarter; The growth rate of media, communications and automobiles is also higher than 40%. In terms of individual stocks, Oriental Fortune received the most financing customers, with a net purchase amount of 15.892 billion yuan; SMIC ranked second with a net purchase of 5.515 billion yuan; Jianghuai Automobile ranked third with a net purchase of 4.122 billion yuan. Among the TOP20 stocks, there are many non-bank financial, automobile, computer and semiconductor stocks, accounting for 50% of the total. (data treasure)Huawang Technology: Zhang Yancheng, the director, plans to reduce the company's shares by no more than 0.3443%. Huawang Technology announced that Zhang Yancheng, the company's director and senior manager, plans to reduce the company's shares by no more than 1.6 million shares through centralized bidding on the Shanghai Stock Exchange within three months after the announcement date, accounting for 0.3443% of the company's total share capital. The reduction price will be determined according to the market price. Zhang Yancheng currently holds 6,671,700 shares of the company, accounting for 1.4357% of the company's total share capital.